Description

2-oxo-2-[[(3R,7S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(2R)-pentan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]amino]acetic acid is a high-purity steroidal derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical chemical intermediate for synthesizing novel therapeutic agents, particularly in the fields of endocrinology and metabolic disease. Its complex, defined stereochemistry makes it essential for researchers and manufacturers requiring precise molecular building blocks to ensure the efficacy and safety of final drug products.

Application

• Pharmaceutical Intermediate: A key starting material or synthetic precursor in the research and production of steroidal drugs and hormone analogs.
• Research & Development (R&D): Used in academic and industrial laboratories for studying structure-activity relationships (SAR) and developing new bioactive molecules.
• Active Pharmaceutical Ingredient (API) Synthesis: Employed in multi-step synthetic routes to create complex, high-value target molecules for clinical evaluation.
• Biochemical Research: Serves as a tool compound for investigating steroid receptor interactions and metabolic pathways.
• Process Chemistry: Utilized in the scale-up and optimization of synthetic manufacturing processes for pharmaceutical candidates.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development, validation, and quality control testing.

Basic Information

Product Name	2-oxo-2-[[(3R,7S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(2R)-pentan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]amino]acetic acid
CAS No.	68753-51-5
Molecular Formula	C₂₆H₄₁NO₆
Molecular Weight	463.61 g/mol
Synonyms	3α,7α,12α-Trihydroxy-5β-cholan-24-oylglycine; Glycocholenic acid; N-(3α,7α,12α-Trihydroxy-5β-cholan-24-oyl)glycine; Glycocholic acid derivative; Steroidal glycine conjugate; 5β-Cholan-24-oic acid, 3,7,12-trihydroxy-, (2-aminoacetyl)-, (3α,5β,7α,12α)-; Cholanoic acid glycine conjugate
EINECS	Contact for details

Quality Control

Our 2-oxo-2-[[(3R,7S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(2R)-pentan-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]amino]acetic acid is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical research. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting the specific results for your quality assurance records.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); ensure the container is sealed after each use to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.